Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of “Hold” by Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have received a consensus recommendation of “Hold” from the thirteen ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokers that have covered the stock in the last year is $2.7727.

A number of research analysts have recently weighed in on the company. Stifel Nicolaus cut their price objective on Health Catalyst from $3.75 to $2.00 and set a “hold” rating for the company in a research report on Friday, March 13th. Stephens dropped their price objective on shares of Health Catalyst from $2.00 to $1.75 and set an “equal weight” rating for the company in a research note on Tuesday, May 12th. Cantor Fitzgerald reissued a “neutral” rating on shares of Health Catalyst in a research note on Monday, May 11th. Wells Fargo & Company reissued an “equal weight” rating and issued a $1.00 price objective (down from $5.00) on shares of Health Catalyst in a research note on Wednesday, March 18th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Health Catalyst in a research note on Friday, March 27th.

Hedge Funds Weigh In On Health Catalyst

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Renaissance Technologies LLC purchased a new position in shares of Health Catalyst in the 1st quarter worth $276,000. Sei Investments Co. grew its stake in shares of Health Catalyst by 76.6% in the 1st quarter. Sei Investments Co. now owns 169,327 shares of the company’s stock worth $215,000 after buying an additional 73,421 shares in the last quarter. Hsbc Holdings PLC grew its stake in shares of Health Catalyst by 21.3% in the 1st quarter. Hsbc Holdings PLC now owns 98,868 shares of the company’s stock worth $123,000 after buying an additional 17,332 shares in the last quarter. Invesco Ltd. grew its stake in shares of Health Catalyst by 6.5% in the 4th quarter. Invesco Ltd. now owns 118,591 shares of the company’s stock worth $283,000 after buying an additional 7,186 shares in the last quarter. Finally, Strong Retirement Solutions LLC purchased a new position in shares of Health Catalyst in the 4th quarter worth $89,000. 85.00% of the stock is owned by hedge funds and other institutional investors.

Health Catalyst Stock Down 1.1%

Shares of HCAT stock opened at $1.72 on Tuesday. The company has a market capitalization of $127.09 million, a price-to-earnings ratio of -0.46 and a beta of 1.66. Health Catalyst has a one year low of $0.96 and a one year high of $4.13. The company’s fifty day moving average price is $1.44 and its 200-day moving average price is $1.78. The company has a debt-to-equity ratio of 1.10, a current ratio of 1.69 and a quick ratio of 1.69.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Monday, May 11th. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. The firm had revenue of $70.76 million during the quarter, compared to analyst estimates of $69.24 million. Health Catalyst had a negative return on equity of 3.52% and a negative net margin of 87.69%. Sell-side analysts expect that Health Catalyst will post -0.25 EPS for the current fiscal year.

About Health Catalyst

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.